NCT04796285View on ClinicalTrials.gov

A Validation Study of the Lab Clasp Device: A Point of Care Sepsis Risk Monitor

NAUnknownINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

May 31, 2024

Study Completion Date

August 31, 2024

Conditions
SepsisSepsis BacterialLactate Blood IncreaseInfectious Disease
Interventions
DEVICE

Lab Clasp

Finger-based interstitial fluid assessment device

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

Sponsors
All Listed Sponsors
collaborator

Cambridge Medical Technologies, LLC

INDUSTRY

lead

Brigham and Women's Hospital

OTHER

NCT04796285 - A Validation Study of the Lab Clasp Device: A Point of Care Sepsis Risk Monitor | Biotech Hunter | Biotech Hunter